Heron Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.81

+0.01 (+1.50%)

As of Apr 1, 2:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +2,708.8% upside

Low Target $15.42

Average Target $22.81

High Target $25.92

Current Price $0.81

Current
$0.81

Target
$22.81

$15.42 $22.81 avg $25.92

Scenario Analysis

Bear Case

$15.42

1,798.8%

Low target

Base Case

$22.81

+2,708.8%

Avg target

Bull Case

$25.92

+3,091.7%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$2.68

-69.7% from high

52-Week Low

$1.00

+-18.8% from low

Target vs 52W High

$22.81

+751.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%